Publications 2020

Brana Q, Thibault F, Courtehoux M, Metrard G, Ribeiro MJ, Angoulvant D, Bailly M. Regadenoson versus dipyridamole: Evaluation of stress myocardial blood flow response on a CZT-SPECT camera. J Nucl Cardiol. 2022 Feb;29(1):113-122. doi: 10.1007/s12350-020-02271-5. Epub 2020 Jul 10.

Bensalem, A., Mulleman, D., Paintaud, G., Azzopardi, N., Gouilleux-Gruart, V., Cornec, D., Specks, U., Ternant, D., 2020. Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited. Clin Pharmacokinet 59, 519–530. https://doi.org/10.1007/s40262-019-00826-5

Bensalem, A., Ternant, D., 2020. Pharmacokinetic Variability of Therapeutic Antibodies in Humans: A Comprehensive Review of Population Pharmacokinetic Modeling Publications. Clin Pharmacokinet. https://doi.org/10.1007/s40262-020-00874-2

Bodin, A., Bisson, A., Gaborit, C., Herbert, J., Clementy, N., Babuty, D., Lip, G.Y.H., Fauchier, L., 2020. Ischemic Stroke in Patients With Sinus Node Disease, Atrial Fibrillation, and Other Cardiac Conditions. Stroke 51, 1674–1681. https://doi.org/10.1161/STROKEAHA.120.029048

Dănilă, M.-D., Piollet, M., Aburel, O.-M., Angoulvant, D., Lefort, C., Chadet, S., Roger, S., Muntean, M.-D., Ivanes, F., 2020. Modulation of P2Y11-related purinergic signaling in inflammation and cardio-metabolic diseases. Eur. J. Pharmacol. 876, 173060. https://doi.org/10.1016/j.ejphar.2020.173060

Chadet S, Ternant D, Roubille F, Bejan-Angoulvant T, Prunier F, Mewton N, Paintaud G, Ovize M, Dupuy AM, Angoulvant D, Ivanes F.,  Kinetic modelling of myocardial necrosis biomarkers offers an easier, reliable and more acceptable assessment of infarct size. Sci Rep. 2020 Aug 12;10(1):13597. doi: 10.1038/s41598-020-70501-4.
https://pubmed.ncbi.nlm.nih.gov/32788683/

 

Poisson L, Lopez-Charcas O, Chadet S, Bon E, Lemoine R, Brisson L, Ouaissi M, Baron C, Besson P, Roger S, Moussata D. Rock inhibition promotes Na_V1.5 sodium channel-dependent SW620 colon cancer cell invasiveness.  Sci Rep. 2020 Aug 7;10(1):13350. doi: 10.1038/s41598-020-70378-3
https://pubmed.ncbi.nlm.nih.gov/32770034/
 

Brisson L., Chadet S., Lopez-Charcas O., Jelassi B., Ternant D., Chamouton J., Lerondel S., Le Pape A., Couillin I., Gombault A., Trovero F., Chevalier S., Besson P., Jiang L.-H. , Roger S. P2X7 receptor promotes mouse mammary cancer cell invasiveness and tumour progression, and is a target for anticancer treatment. Cancers. 2020, 12, 2342; doi:10.3390/cancers12092342
https://pubmed.ncbi.nlm.nih.gov/32825056/
 

Granel J, Lemoine R, Morello E, Gallais Y, Mariot J, Drapeau M, Musnier A, Poupon A, Pugnière M, Seren S, Nouar D, Gouilleux-Gruart V, Watier H, Korkmaz B, Hoarau C. 4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis. Front.Immunol. 2020 Sept 25.
https://doi.org/10.3389/fimmu.2020.573040
 

Buggisch JR, Göhler D, Le Pape A, Roger S, Ouaissi M, Stintz M, Rudolph A, Giger-Pabst U. Experimental Model to Test Electrostatic Precipitation Technology in the COVID-19 Era: A Pilot Study. J Am Coll Surg. 2020 Sep 3:S1072-7515(20)32299-7. doi: 10.1016/j.jamcollsurg.2020.08.759.
https://pubmed.ncbi.nlm.nih.gov/32891798/

Rat, V., Pinson, X., Seigneuret, F., Durand, S., Herrscher, C., Lemoine, R., Burlaud-Gaillard, J., Raynal, P.-Y., Hourioux, C., Roingeard, P., Tramier, M., de Rocquigny, H., 2020. Hepatitis B Virus Core Protein Domains Essential for Viral Capsid Assembly in a Cellular Context. J. Mol. Biol.
https://doi.org/10.1016/j.jmb.2020.04.026

Mesnier, J., Cottin, Y., Coste, P., Ferrari, E., Schiele, F., Lemesle, G., Thuaire, C., Angoulvant, D., Cayla, G., Bouleti, C., Gallet de Saint Aurin, R., Goube, P., Lhermusier, T., Dillinger, J.-G., Paganelli, F., Saib, A., Prunier, F., Vanzetto, G., Dubreuil, O., Puymirat, E., Boccara, F., Eltchaninoff, H., Cachanado, M., Rousseau, A., Drouet, E., Steg, P.-G., Simon, T., Danchin, N., 2020. Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study. Lancet Public Health 5, e536–e542. https://doi.org/10.1016/S2468-2667(20)30188-2

Coudert B., Pierga J.-Y., Mouret-Reynier M.-A., Kerrou K., Ferrero J.-M., Petit T., Le Du F., Dupré J.-F., Bachelot T., Gabelle P., Chauvet M.-P., Coeffic D., Barbe C., Prevost J.-B., Paintaud G., Thibault G., Ferhat A., Dupin J., Berriolo-Riedinger A., Arnould L.. Long-term outcomes in patients with PET-predicted poor-responsiveHER2-positive breast cancer treated with neoadjuvant bevacizumabadded to trastuzumab and docetaxel: 5-year follow-up of the randomised Avataxher study. EClinicalMedicine, (2020) 100566. https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30310-2/fulltext

Coudert, B., Pierga, J.-Y., Mouret-Reynier, M.-A., Kerrou, K., Ferrero, J.-M., Petit, T., Kerbrat, P., Dupré, P.-F., Bachelot, T., Gabelle, P., Giard, S., Coeffic, D., Bougnoux, P., Prevost, J.-B., Paintaud, G., Thibault, G., Hernandez, J., Coudert, M., Arnould, L., Berriolo-Riedinger, A., 2014. Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial. Lancet Oncol 15, 1493–1502. https://doi.org/10.1016/S1470-2045(14)70475-9

Bodin A, Labas V, Bisson A, Teixeira-Gomes AP, Blasco H, Tomas D, Combes-Soia L, Marcelo P, Miquelestorena-Standley E, Baron C, Angoulvant D, Babuty D,Clementy N.  Acute pathophysiological myocardial changes following intra-cardiac electrical shocks using a proteomic approach in a sheep model. Sci Rep. 2020 Nov 20;10(1):20252. doi: 10.1038/s41598-020-77346-x
https://pubmed.ncbi.nlm.nih.gov/33219330/

Bailly, E., Stefic, K., Gatault, P., Miquelestorena-Standley, E., Machet, M.-C., Barbet, C., Barin, F., Halimi, J.-M., 2020. Prevention of parvovirus B19-induced repetitive acute kidney failure by subcutaneous immunoglobulins. Fundam Clin Pharmacol 34, 296–298.
https://doi.org/10.1111/fcp.12511

Sabouret, P., Galati, G., Angoulvant, D., Germanova, O., Castelletti, S., Pathak, A., Metra, M., Margonato, A., 2020. The interplay between cardiology and diabetology: a renewed collaboration to optimize cardiovascular prevention and heart failure management. Eur Heart J Cardiovasc Pharmacother. PMID: 32402065
https://doi.org/10.1093/ehjcvp/pvaa051

Gatault, P., Lajoie, L., Stojanova, J., Halimi, J.-M., Caillard, S., Moyrand, S., Martinez, D., Ladrière, M., Morelon, E., Merville, P., Essig, M., Vigneau, C., Kamar, N., Bouvier, N., Westeel, P.-F., Mariat, C., Hazzan, M., Thierry, A., Etienne, I., Büchler, M., Marquet, P., Gouilleux-Gruart, V., Thibault, G., 2020. The FcγRIIIA-158 VV genotype increased the risk of post-transplant lymphoproliferative disorder in T-cell-depleted kidney transplant recipients - a retrospective study. Transpl. Int.
https://doi.org/10.1111/tri.13624

de Freminville JB, Vernier LM, Roumy J, Patat F, Gatault P, Sautenet B, Bailly E, Chevallier E, Barbet C, Longuet H, Merieau E, Baron C, Buchler M, Halimi JM. The association between renal resistive index and premature mortality after kidney transplantation is modified by pre-transplant diabetes status: a cohort study.  Nephrol Dial Transplant. 2020 Sep 1;35(9):1577-1584. doi: 10.1093/ndt/gfz067
https://pubmed.ncbi.nlm.nih.gov/31028403/

Passot C, Sberro-Soussan R, Bertrand D, Caillard S, Schvartz B, Domenger C, Contin-Bordes C, Paintaud G, Halimi JM, Ternant D, Gatault P. Feasibility and safety of tailored dosing schedule for eculizumab based on therapeutic drug monitoring: lessons from a prospective multicentric study. Br J Clin Pharmacol. 2020 Oct 28. doi: 10.1111/bcp.14627. Online ahead of print. Br J Clin Pharmacol. 2020. PMID: 33118186
https://pubmed.ncbi.nlm.nih.gov/33118186/

Lantelme, P., Lacour, T., Bisson, A., Herbert, J., Ivanes, F., Bourguignon, T., Quilliet, L., Angoulvant, D., Harbaoui, B., Babuty, D., Etienne, C.S., Deharo, P., Bernard, A., Fauchier, L., 2020. Futility Risk Model for Predicting Outcome After Transcatheter Aortic Valve Implantation. Am. J. Cardiol.
https://doi.org/10.1016/j.amjcard.2020.05.043

Rezniczek GA, Buggisch J, Sobilo J, Launay A, Lerondel S, Le Pape A, Ouaissi M, Göhler D, Senkal M, Giger-Pabst U, Establishment of a Mouse Ovarian Cancer and Peritoneal Metastasis Model to Study Intraperitoneal Chemotherapy. Tempfer CB.Cancers (Basel). 2020 Dec 17;12(12):3818. doi: 10.3390/cancers12123818.

Granel J, Lemoine R, Morello E, Gallais Y, Mariot J, Drapeau M, Musnier A, Poupon A, Pugnière M, Seren S, Nouar D, Gouilleux-Gruart V, Watier H, Korkmaz B, Hoarau C. 4C3 Human Monoclonal Antibody: A Proof of Concept for Non-pathogenic Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies in Granulomatosis With Polyangiitis. Front Immunol. 2020 Sep 25;11:573040. doi: 10.3389/fimmu.2020.573040. eCollection 2020.PMID: 33101296